Coya Therapeutics (COYA) Net Equity Issued and Repurchased (2024 - 2026)
Coya Therapeutics (COYA) reported Net Equity Issued and Repurchased of $11.0 million for Q1 2026, up 21.35% sequentially from $9.1 million in Q4 2024.
Coya Therapeutics (COYA) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $11.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | 11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00 Mn |
| Mar 31, 2026 | 11.00 Mn |
| Dec 31, 2024 | 9.06 Mn |
| Dec 31, 2024 | 9.06 Mn |
| Sep 30, 2024 | -56,332.00 |
| Sep 30, 2024 | -56,332.00 |